Pancreatic Cancer Research

ResearcherColumbia UniversityNo recent work listed

William H. Sherman

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5111871776. Sources: ClinicalTrials.gov.

Their work

Papers
1
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2009: 1 trial · 2010: none · 2011: none · 2012: none · 2013: none · 2014: none · 2015: 1 paper

Papers 1

  1. Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable p… Co-author DOI 10.1002/cncr.29112↗

Trials 1

  1. Neoadjuvant GTX With Chemoradiation for Pancreatic Cancer (Stage II/III) Principal investigator NCT01065870↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Elizabeth M. Hecht · 1 shared paper, 2015 · strength 0.04
  2. Robert Lance Fine · 1 shared paper, 2015 · strength 0.04
  3. Beth Schrope · 1 shared paper, 2015 · strength 0.04
  4. John A. Chabot · 1 shared paper, 2015 · strength 0.04
  5. John Allendorf · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.